Circulating miRNAs as novel potential biomarkers for esophageal squamous cell carcinoma diagnosis: a meta-analysis update

被引:27
作者
Liu, Fen [1 ,2 ]
Tian, Tian [1 ,3 ]
Xia, Li-Li [1 ,2 ]
Ding, Yuanjie [1 ,2 ]
Cormier, Robert T. [4 ]
He, Yan [1 ,2 ]
机构
[1] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing 100069, Peoples R China
[2] Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China
[3] Peking Univ, Inst Reprod & Child Hlth, Dept Epidemiol & Biostat, Sch Publ Hlth, Beijing, Peoples R China
[4] Univ Minnesota, Dept Biomed Sci, Med Sch Duluth, Duluth, MN 55812 USA
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
circulating miRNAs; diagnosing; esophageal squamous cell carcinoma; meta-analysis; SYSTEMATIC REVIEWS; CARCINOEMBRYONIC ANTIGEN; MICRORNA BIOMARKERS; EXPRESSION PROFILE; CLINICAL UTILITY; BREAST-CANCER; SERUM; PLASMA; IDENTIFICATION; PERFORMANCE;
D O I
10.1111/dote.12489
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Early detection of esophageal squamous cell carcinoma (ESCC) is urgently needed to reduce the high morbidity and mortality of disease. Circulating microRNAs (miRNAs) are promising molecular biomarkers for ESCC prediction. We performed a comprehensive meta-analysis to systematically evaluate the diagnostic accuracy of circulating miRNAs in diagnosis of ESCC patients. Eligible studies were identified and assessed for quality employing multiple search strategies. Summary estimates for sensitivity, specificity, and other measures of accuracy of miRNAs in the diagnosis of ESCC were pooled using the bivariate random effects model. Atotal of 27 studies from 11 published articles were included in the meta-analysis. The overall sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, and diagnostic odds ratio of circulating miRNAs for the diagnosis of ESCC were 79.9% (95% confidence intervals [CI]: 76.2%-83.1%), 81.3% (95% CI: 75.7-85.9), 4.27 (95% CI: 3.27-5.58), 0.25 (95% CI: 0.21-0.29), and 17.29 (95% CI: 12.01-24.86), respectively. The area under the summary receiver operating characteristic curve was 0.87 (95% CI: 0.84-0.90). The subgroup analyses based on research country (China vs. Japan), specimen type (plasma vs. serum), miRNAs profiling (single vs. multiple), and test method (screening vs. candidate; Taqman vs. SYBR) indicated no significant difference in the diagnostic accuracy of each subgroup. Collectively, our findings indicate that circulating miRNAs have significant potential to be used as noninvasive biomarkers for early detection of ESCC. Moreover, the subgroup analyses demonstrated the feasibility of using blood miRNAs as an ESCC diagnostic biomarker in Japanese and Chinese populations. Further, both plasma and serum are recommended as clinical specimens for miRNA detection. Further studies will be needed to validate these findings using larger numbers of patients.
引用
收藏
页数:9
相关论文
共 52 条
[1]   Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma [J].
Arroyo, Jason D. ;
Chevillet, John R. ;
Kroh, Evan M. ;
Ruf, Ingrid K. ;
Pritchard, Colin C. ;
Gibson, Donald F. ;
Mitchell, Patrick S. ;
Bennett, Christopher F. ;
Pogosova-Agadjanyan, Era L. ;
Stirewalt, Derek L. ;
Tait, Jonathan F. ;
Tewari, Muneesh .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (12) :5003-5008
[2]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[3]   MicroRNAome Genome: A Treasure for Cancer Diagnosis and Therapy [J].
Berindan-Neagoe, Ioana ;
Monroig, Paloma del C. ;
Pasculli, Barbara ;
Calin, George A. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2014, 64 (05) :311-336
[4]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[5]   Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases [J].
Chen, Xi ;
Ba, Yi ;
Ma, Lijia ;
Cai, Xing ;
Yin, Yuan ;
Wang, Kehui ;
Guo, Jigang ;
Zhang, Yujing ;
Chen, Jiangning ;
Guo, Xing ;
Li, Qibin ;
Li, Xiaoying ;
Wang, Wenjing ;
Zhang, Yan ;
Wang, Jin ;
Jiang, Xueyuan ;
Xiang, Yang ;
Xu, Chen ;
Zheng, Pingping ;
Zhang, Juanbin ;
Li, Ruiqiang ;
Zhang, Hongjie ;
Shang, Xiaobin ;
Gong, Ting ;
Ning, Guang ;
Wang, Jun ;
Zen, Ke ;
Zhang, Junfeng ;
Zhang, Chen-Yu .
CELL RESEARCH, 2008, 18 (10) :997-1006
[6]   Shedding microvesicles: artefacts no more [J].
Cocucci, Emanuele ;
Racchetti, Gabriella ;
Meldolesi, Jacopo .
TRENDS IN CELL BIOLOGY, 2009, 19 (02) :43-51
[7]   Diagnostic value of circulating microRNAs as biomarkers for breast cancer: a meta-analysis study [J].
Cui, Zhaolei ;
Lin, Donghong ;
Song, Wenfang ;
Chen, Meihuan ;
Li, Dan .
TUMOR BIOLOGY, 2015, 36 (02) :829-839
[8]   Systematic reviews in health care - Systematic reviews of evaluations of diagnostic and screening [J].
Deeks, JJ .
BRITISH MEDICAL JOURNAL, 2001, 323 (7305) :157-162
[9]   The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed [J].
Deeks, JJ ;
Macaskill, P ;
Irwig, L .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2005, 58 (09) :882-893
[10]   A methodological review of how heterogeneity has been examined in systematic reviews of diagnostic test accuracy [J].
Dinnes, J ;
Deeks, J ;
Kirby, J ;
Roderick, P .
HEALTH TECHNOLOGY ASSESSMENT, 2005, 9 (12) :1-+